REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Millennium Pharmacon International Tbk (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Millennium Pharmacon International Tbk Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT. Millennium Pharmacon International Tbk. (SDPC), operates in activities relating to distribution of pharmaceuticals, nutritional and consumer goods. SDPC also provides medical supplies (prescription and non-prescription) and medical equipment to government institutions. SDPC was listed on Indonesia Stock Exchange in 1990 under the Development Board. The company was founded in 1952 and based in Jakarta, Indonesia.

Headquarters
Crown Bungur Arteri 2-4Th Floors, Jl. Sultan Iskandar Muda No.18, Kebayoran Lama
Jakarta; Jakarta; Postal Code: 12240

Contact Details: Purchase the Pt Millennium Pharmacon International Tbk report to view the information.

Website: http://www.mpi-indonesia.co.id

Basic Information
Total Employees:
Purchase the Pt Millennium Pharmacon International Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Millennium Pharmacon International Tbk report to view the information.
Financial Auditors:
Purchase the Pt Millennium Pharmacon International Tbk report to view the information.
Incorporation Date:
1952
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
11.63%
Purchase this report to view the information.
9.72%
Company Performance
Financial values in the chart are available after Pt Millennium Pharmacon International Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
1.94%
Total operating revenue
2.63%
Operating profit (EBIT)
25.84%
EBITDA
24.64%
Net Profit (Loss) for the Period
12.12%
Total assets
13.14%
Total equity
11.16%
Operating Profit Margin (ROS)
0.7%
Net Profit Margin
0.1%
Return on Equity (ROE)
0.08%
Debt to Equity Ratio
33.48%
Quick Ratio
0.02%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?